Literature DB >> 12578925

Patterns of health care utilization for migraine in England and in the United States.

R B Lipton1, A I Scher, T J Steiner, M E Bigal, K Kolodner, J N Liberman, W F Stewart.   

Abstract

OBJECTIVE: To assess patterns of medical consultation, diagnosis, and medication use in representative samples of adults with migraine in England and the United States.
METHODS: Validated computer-assisted telephone interviews were conducted in the United Kingdom (n = 4,007) and the United States (n = 4,376). Individuals who reported six or more headaches per year meeting the criteria for migraine were interviewed.
RESULTS: Patients with migraine in the United Kingdom were more likely to have consulted a doctor for headache at least once in their lifetime (86% vs 69%, p < 0.0001), but also were more likely to have lapsed from medical care (37% vs 21%, p < 0.001). In the United States, patients with migraine who had consulted made more office visits for headache and were more likely to see a specialist. In the United States, but not in the United Kingdom, women with migraine were more likely than men to consult doctors for headache. Patients with migraine in the United Kingdom were more likely to receive a medical diagnosis of migraine (UK 67%, US 56%; p < 0.05). Patterns of medication use were similar in both countries, with most people treating with over-the-counter (OTC) medications. Substantial disability occurred in a high proportion of those who never consulted (UK 60%, US 68%), never received a correct medical diagnosis (UK 64%, US 77%), and treated only with OTC medication (UK 72%, US 70%).
CONCLUSION: Medically unrecognized migraine remains an important health problem both in the United States and the United Kingdom. Furthermore, there may be barriers to consultation for men in the United States that do not operate in the United Kingdom.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12578925     DOI: 10.1212/wnl.60.3.441

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  41 in total

1.  Genomic expression patterns in medication overuse headaches.

Authors:  Andrew D Hershey; Danny Burdine; Marielle A Kabbouche; Scott W Powers
Journal:  Cephalalgia       Date:  2010-06-02       Impact factor: 6.292

2.  Migraine in men: fact sheet. A publication to mark European Migraine Day of Action 2014.

Authors:  Paolo Rossi; Giuseppe Nappi
Journal:  Funct Neurol       Date:  2014 Jul-Sep

3.  Treatment of migraine and tension-type headache in Croatia.

Authors:  Vlasta Vuković; Davor Plavec; Arijana Lovrencić Huzjan; Mislav Budisić; Vida Demarin
Journal:  J Headache Pain       Date:  2010-03-06       Impact factor: 7.277

4.  Activation of pial and dural macrophages and dendritic cells by cortical spreading depression.

Authors:  Aaron J Schain; Agustin Melo-Carrillo; David Borsook; Jaime Grutzendler; Andrew M Strassman; Rami Burstein
Journal:  Ann Neurol       Date:  2018-03-13       Impact factor: 10.422

Review 5.  Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.

Authors:  Paul L McCormack; Rachel H Foster
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

6.  Secular changes in health care utilization and work absence for migraine and tension-type headache: a population based study.

Authors:  A C Lyngberg; B K Rasmussen; T Jørgensen; R Jensen
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 7.  Outcome of Chronic Daily Headache or Chronic Migraine.

Authors:  Soo-Jin Cho; Tae-Jin Song; Min Kyung Chu
Journal:  Curr Pain Headache Rep       Date:  2016-01

8.  Preventive pharmacologic treatments for episodic migraine in adults.

Authors:  Tatyana A Shamliyan; Jae-Young Choi; Rema Ramakrishnan; Jennifer Biggs Miller; Shi-Yi Wang; Frederick R Taylor; Robert L Kane
Journal:  J Gen Intern Med       Date:  2013-04-17       Impact factor: 5.128

9.  Children and adolescents with headache: what do they need?

Authors:  David Kernick; Deborah Reinhold
Journal:  J Headache Pain       Date:  2008-06-10       Impact factor: 7.277

10.  Differences between the United States and the United Kingdom in the treatment of rheumatoid arthritis: analyses from a hand arthroplasty trial.

Authors:  Kevin C Chung; Sandra V Kotsis; David A Fox; Marian Regan; Frank D Burke; E F Shaw Wilgis; H Myra Kim
Journal:  Clin Rheumatol       Date:  2010-04       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.